FASN is a potential therapeutic target for ARID1A‐deficient pancreatic cancer.Mutations in AT‐rich interactive domain‐containing protein 1A (ARID1A) gene are frequently found in pancreatic cancer. This evidence concerns the gene FASN and pancreatic neoplasm.